Cardiff Oncology, Inc. (CRDF) released Loss for its full year of -$45.46 million
The company's bottom line totaled -$45.46 million, or -$0.95 per share. This compares with -$41.47 million, or -$0.93 per share, last year.
The company's revenue for the period rose 38.8% to $0.68 million from $0.49 million last year.
Cardiff Oncology, Inc. earnings at a glance (GAAP) :
-Earnings: -$45.46 Mln. vs. -$41.47 Mln. last year.
-EPS: -$0.95 vs. -$0.93 last year.
-Revenue: $0.68 Mln vs. $0.49 Mln last year.
For comments and feedback: editorial@rttnews.com